136 related articles for article (PubMed ID: 19287074)
1. Prognostic utility of glycosyltransferase expression in breast cancer.
Patani N; Jiang W; Mokbel K
Cancer Genomics Proteomics; 2008; 5(6):333-40. PubMed ID: 19287074
[TBL] [Abstract][Full Text] [Related]
2. UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cells.
Freire T; Berois N; Sóñora C; Varangot M; Barrios E; Osinaga E
Int J Cancer; 2006 Sep; 119(6):1383-8. PubMed ID: 16596643
[TBL] [Abstract][Full Text] [Related]
3. UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
Berois N; Mazal D; Ubillos L; Trajtenberg F; Nicolas A; Sastre-Garau X; Magdelenat H; Osinaga E
J Histochem Cytochem; 2006 Mar; 54(3):317-28. PubMed ID: 16260590
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of glycosyltransferase mRNA expression in gastric cancer.
Bhat SA; Mir MUR; Majid S; Hassan T; Rehman MU; Kuchy S
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):158-168. PubMed ID: 29729225
[TBL] [Abstract][Full Text] [Related]
5. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
Salhab M; Patani N; Jiang W; Mokbel K
Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
Brooks SA; Carter TM; Bennett EP; Clausen H; Mandel U
Acta Histochem; 2007; 109(4):273-84. PubMed ID: 17448526
[TBL] [Abstract][Full Text] [Related]
7. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
Julien S; Adriaenssens E; Ottenberg K; Furlan A; Courtand G; Vercoutter-Edouart AS; Hanisch FG; Delannoy P; Le Bourhis X
Glycobiology; 2006 Jan; 16(1):54-64. PubMed ID: 16135558
[TBL] [Abstract][Full Text] [Related]
8. The mRNA expression of SATB1 and SATB2 in human breast cancer.
Patani N; Jiang W; Mansel R; Newbold R; Mokbel K
Cancer Cell Int; 2009 Jul; 9():18. PubMed ID: 19642980
[TBL] [Abstract][Full Text] [Related]
9. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
Sasi W; Jiang WG; Sharma A; Mokbel K
BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
Jiang WG; Douglas-Jones AG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
[TBL] [Abstract][Full Text] [Related]
12. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of alpha2,8 sialyltransferase and increased expression of beta1,4 N-acetylgalactosaminyltransferase in gastrointestinal cancers.
Koh Y; Tsunoda T; Iwahashi M; Yamaue H; Ishimoto K; Tanimura H; Fukumoto H; Nakamura T; Tatsumi Y; Shimizu M; Saijo N; Nishio K
Exp Biol Med (Maywood); 2002 Mar; 227(3):196-200. PubMed ID: 11856818
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer.
Patani N; Jiang WG; Mokbel K
Cancer Cell Int; 2011 Jul; 11(1):23. PubMed ID: 21767406
[TBL] [Abstract][Full Text] [Related]
15. Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.
Gomes J; Marcos NT; Berois N; Osinaga E; Magalhães A; Pinto-de-Sousa J; Almeida R; Gärtner F; Reis CA
J Histochem Cytochem; 2009 Jan; 57(1):79-86. PubMed ID: 18854599
[TBL] [Abstract][Full Text] [Related]
16.
Lavrsen K; Dabelsteen S; Vakhrushev SY; Levann AMR; Haue AD; Dylander A; Mandel U; Hansen L; Frödin M; Bennett EP; Wandall HH
J Biol Chem; 2018 Jan; 293(4):1298-1314. PubMed ID: 29187600
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Wu C; Guo X; Wang W; Wang Y; Shan Y; Zhang B; Song W; Ma S; Ge J; Deng H; Zhu M
BMC Cancer; 2010 Apr; 10():123. PubMed ID: 20356418
[TBL] [Abstract][Full Text] [Related]
18. Absence of intraepidermal glycosyltransferase ppGalNac-T3 expression in familial tumoral calcinosis.
Topaz O; Bergman R; Mandel U; Maor G; Goldberg R; Richard G; Sprecher E
Am J Dermatopathol; 2005 Jun; 27(3):211-5. PubMed ID: 15900124
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.
Patani N; Jiang W; Newbold R; Mokbel K
J Carcinog; 2010 Nov; 9():9. PubMed ID: 21139993
[TBL] [Abstract][Full Text] [Related]
20. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
